Year: 2022

3 January December traffic volumes3 February January traffic volumes22 February Unaudited 12-months interim report3 March February traffic volumes4 April March traffic volumes27 April Unaudited 3-months interim report3 May April traffic volumes5 June May traffic volumes4 July June traffic volumes27 July Unaudited 6-months interim report3 August July traffic volumes5 September August traffic volumes3 October September traffic volumes26 October Unaudited 9-months interim report3 November October traffic volumes5 December November traffic volumesAnneli Simm Investor Relations Coordinator AS Tallink Grupp Sadama 5 10111 Tallinn, Estonia E-mail: anneli.simm@tallink.ee

Panevezio statybos trestas AB has signed the 21,7 million Euro (excl. VAT) provisional sum contract with the General Contractor, Petrofac International UAE LLC, for the civil works in Factory Modernization Project at ORLEN Lietuva AB in Mazeikiai. The scope of the main works includes installation of pavements, roads and foundation. Panevezio statybos trestas AB plans to complete the civil works by September 2024. More information:Managing DirectorEgidijus UrbonasTel.: (+370 45) 505 503

AUGA group, AB (hereinafter, the “Company”) presented the Company‘s unaudited financial results for the 9 months of 2022 in an online webinar for investors on December 5 of 2022. The presentation (see attachment) covers detailed information on the results of each business segment of the Company and general financial indicators.  Mindaugas Ambrasas, CFO of the Company, presented the results and answered questions from webinar participants. The webinar was recorded. It will be available to see on Nasdaq Baltic youtube.com account and the Company’s website.  Contacts: Mindaugas Ambrasas, AUGA group, AB CFO Phone: +370 620 67296 Email: m.ambrasas@auga.lt    AttachmentPresentation

FINANCIAL RELEASE 6 December 2022 Aéroports de Paris SAEvolution in Groupe ADP’s share capital allowing the finalization of the process of unwinding the cross-shareholdings with Royal Schiphol Group Royal Schiphol Group today announced the sale of its remaining stake in Aéroports de Paris (“Groupe ADP”). This sale represented approximately 3.91% of Groupe ADP’s capital, i.e. 3,869,859 shares. It was carried out by way of an accelerated book-building (ABB) at a price of 133 euros per share. On this occasion, Groupe ADP bought back 296,882 shares, i.e. approximately 0.3 % of the share capital, at a unit price of133 euros. The settlement is expected to take place on or around December 8, 2022. This share buyback, amounting to c. 39.5 million euros, is financed with Groupe ADP’s available cash. It was carried out within the...

Correction: the sales revenue and gross profit data of the crop growing segment have been corrected. Other financial data of the group published on November 30, 2022 remain unchanged. The correction was made in both languages. AUGA group, AB and its subsidiaries (hereinafter – the Group) improved their operating results in the first nine months of the year.   The sales revenue during the first nine months of 2022 was EUR 57.71 million, an increase of 5% compared to EUR 54.90 million in the same period last year.   In the first nine months of 2022, the Group’s gross profit was EUR 13.14 million, representing an increase of 673% compared to the previous year (EUR 1.70 million). The Group’s net loss from EUR 10.43 million fixed in the three quarters of 2021, decreased to EUR 0.62 million in three quarters of 2022.   The Group‘s...

Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Kinarus report new antiviral data of KIN001 against SARS-CoV-2 Omicron BA.2 and BA.5 subvariants KINFAST Phase 2 trial of KIN001 in ambulatory COVID-19 patients is actively recruitingBasel, Switzerland, 6 December 2022 — Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus”), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, announced new preclinical data showing KIN001’s strong antiviral efficacy against the SARS-CoV-2 Omicron subvariants BA.2 and BA.5. Prof. Ulrich Schubert from the Institute of Clinical and Molecular Virology at the Friedrich-Alexander-Universität Erlangen-Nürnberg,...

Live event and webcast TODAY at 10 AM – 12 PM ET Saint-Herblain (France), December 06, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, is hosting an in-person investor day today in New York City to discuss the Company’s current vaccine pipeline, commercial products, and future directions. Valneva’s Chief Executive Officer Thomas Lingelbach, Chief Financial Officer Peter Bühler, and other members of the Company’s senior leadership team will highlight Valneva’s core near- and mid-term value drivers, including its early- and late-stage development pipeline and commercial vaccine business. Presentations will begin at 10am Eastern Time. The event will also be webcast live and archived on the Events and Presentations page in the Investors section of Valneva’s website. A live Q&A session will follow the...

6 December 2022: Hexagon Agility, a business of Hexagon Composites, has received a new order for TITAN® 53 Mobile Pipeline® modules from REV LNG, a leading full-service mobile energy supply and project development company. The modules will be used to transport and deliver renewable natural gas (RNG) from multiple sites within the US. This order represents an estimated value of USD 16.2 million (approx. NOK 158 million). “To meet aggressive greenhouse gas reduction targets, our customers continue to expand their energy portfolios through the use of RNG as the solution to fight climate change,” said David Kailbourne, President of REV LNG. “We continue to invest in Hexagon Agility’s high-capacity TITAN 53 modules because their proven reliability has allowed us to rapidly expand our RNG portfolio to support customer demand.” “RNG is the only...

Design and Site Work Underway for Company’s First Commercial Lithium Plant EL DORADO, Ark., Dec. 06, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, is pleased to announce it has completed all necessary agreements with LANXESS Corporation to secure access to the proposed commercial lithium plant site (the “Site Access Agreement”) and conduct all required fieldwork to support the Definitive Feasibility Study (DFS) underway. Standard Lithium is also pleased to report that subsequent to signing the Site Access Agreement, the Company has commenced the site work necessary for the design of its first commercial lithium plant. Dr. Andy Robinson, President of Standard Lithium commented, “The Company is pleased to...